Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Nīmes
The secondary objectives of this study are to evaluate whether the use of the LC Sprint Sp Nebulizer results in:
A-shortened duration of oxygen-dependence.
B-reduced side effects by assessing the patient's heart rate before and 30 minutes after the first aerosol and noting the occurrence of desaturation \<90% during the nebulisation sessions.
C-increased acceptance of the aerosol, measured via a questionnaire given to the patient's parents at the end of hospitalization (a single questionnaire will be completed by either parent or both parents).
D-shortened length of stay based on the following discharge criteria: observation of a respiratory severity score ≤ 2 (Clinical Asthma Score (CAS)) for at least 12 consecutive hours and a transcutaneous oxygen saturation (SpO2)\> 94% when awake or \> 91% during sleep.
Age
0–3
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The parent or legal representative must have given his/her informed and signed consent
The patient must be insured or beneficiary of a health insurance plan
The patient has an attack of moderate to severe asthma (at least the third episode of wheezing dyspnea since birth) requiring hospitalization defined by the following criteria:
requires oxygen: SpO2 \<92% on room air (if CAS ≤ 4/10)
* And / or CAS\> 4/10 (after 3 attempted nebulized salbutamol sessions over 1 hour of emergency care).
You may not be if
The patient is participating in another study
The patients has already been included in this study a previous time
The patient is in an exclusion period determined by a previous study
The patient is under judicial protection, under tutorship or curatorship
The parent or legal representative refuses to sign the consent
It is impossible to correctly inform the parent or legal representative
The patient has a contra indication for a treatement used in this study
Patient was born at \< 34 weeks of pregnancy or bronchdysplasic
First or second episode of bronchiolitis
Asthma attack with CAS score ≤ 4/10 or inpatient basis for a non-breathing related motive.
Acute severe Asthma attack: hypercapnia, impaired consciousness, need for hospitalization in intensive care, need for mechanical ventilation, need for salbutamol IV
Patient with known congenital heart disease
Patient with chronic respiratory disease other than asthma
Patient with encephalopathy
Patient with known immune deficiency
CAS ≤ 2 and transcutaneous oxygen saturation (SpO2)\> 94% when awake or \> 91% when asleep for at least 12h
Clareo Health | Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age
